NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want ...

Hanmi Pharmaceutical's Countmate targets the vial-based medication packaging market in Canada and the US. Hanmi ...

Avantium and Amcor are collaborating to create plant-based PEF plastic containers for diverse products, with Amcor reserving ...

Boston biotech Kojin Therapeutics is closing its doors, citing four funding challenges and a few valuable lessons learned.  ...

The new system printed a 27-foot-tall architectural demonstration project in Austin. Altogether, Icon's systems have printed ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Glancy Prongay & Murray LLP reminds investors of the upcoming April 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise ...

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

ICON, which builds homes using 3D printing, has closed on $56 million in Series C funding co-led by Norwest Venture Partners ...

Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...

ICON Plc 's stock (NASDAQ:ICLR) has reached a 52-week low, dipping to $183.31, as the company navigates through a turbulent market environment. With a market capitalization of $15.19 billion and a P/E ...